Taxifolin Market By Type (Purity >95% and Purity <95%), By Application (Medicine, Food, and Healthcare Products), and By Region- Trends, Analysis and Forecast till 2034

Taxifolin Market was valued at US$ 85.4 million in 2024 and is projected to grow at a CAGR of 6.0% to reach US$ 144.7 million by 2034.

Taxifolin referred to as dihydroquercetin, is a flavanonol and a type of flavonoid. Taxifolin is found in the plant-based foods like fruits, vegetables, and cocoa. Taxifolin acts as a potential chemo-preventive agent. Taxifolin has excellent properties like anti-microbial, antibacterial, antifungal, and anti-inflammatory. Taxifolin can prevent oxidative stress and shield the body from free radicals. Application areas of taxifolin in the food and beverages industry include dairy products, meat processing, alcoholic and non-alcoholic beverages, and confectionery. Taxifolin and flavonoids in general, can be found in many beverages and products. Specifically, taxifolin is found in plant-based foods like fruit, vegetables, wine, tea, and cocoa. Taxifolin is not mutagenic and less toxic than the related compound quercetin. It acts as a potential chemo-preventive agent by regulating genes via an ARE-dependent mechanism. It also shows to have anti-proliferative effects on many types of cancer cells by inhibiting cancer cell lipogenesis. It enhances the efficiency of some antibiotics like levofloxacin and ceftazidime in vitro, which have the potential for combination therapy of patients infected with methicillin-resistant Staphylococcus aureus.

                      For More Report Details, Download Free Sample PDF

The increasing prevalence of cancer across the globe, coupled with growing demand for taxifolin, owing to its therapeutic properties such as anti-oxidative and anticancer actions are factors driving the growth of the taxifolin market. In addition, increasing the use of taxifolin in food and cosmetic products due to its minimal side effects is another factor expected to propel growth of the target market over the forecast period. Furthermore, the increasing adoption of taxifolin in various end-use applications like sports nutrition, confectioneries, therapeutic dietary supplements, and pharmaceutical products is supporting the growth of the global market. Moreover, taxifolin is used as an additive to food products to enhance the shelf life of food products which is a factor fueling the growth of the taxifolin market.

However, the availability of a substitute to taxifolin is quercetin is a factor hindering the growth of the taxifolin market. Increasing production and development of a strong supply chain of taxifolin beverages is expected to create lucrative growth opportunities for the major players operating in the taxifolin market

The Taxifolin market is segmented based on type, applications, and region.

On the basis of type, the target market is categorized into purity ≥95% and purity <95%. On the basis of application, the taxifolin market is classified into medicine and pharmaceutics, the food processing industry, and healthcare products.

Regional Insights:

In the region, the taxifolin market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in Europe accounted for the highest revenue share in the taxifolin market. This is attributed to the increasing demand for taxifolin in major end-use applications such as food and cosmetics in the countries of the region. In addition, the rising use of taxifolin as an ingredient in various drugs owing to its excellent properties like antibacterial, antifungal, and anti-inflammatory is a factor expected to propel the growth of the target market in the near future. The North America taxifolin market accounts for a significant revenue share in the global taxifolin market. This can be attributed to the increasing demand for taxifolin owing to its wide end-use applications in industries such as food, pharmaceutical, and cosmetics in countries of the region. The Asia Pacific market accounts for a considerable revenue share in the global taxifolin market. This is owing to the increasing demand for taxifolin from various end-use industries; especially in the pharmaceutical industry in China.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global taxifolin market report based on type, application, and region.

Taxifolin Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating in the taxifolin market include Linjiang Jianwei Biotech Co., Ltd., KINGHERBS Limited, JW Health Products Inc., KALENIKA Group, Cayman Chemical Company, Inc., LKT Labs, Inc., Merck KGaA, Abcam plc, Adooq Bioscience LLC, and Hangzhou J&H Chemical Co., Ltd. Technological advancements in the product as well as in manufacturing process, product launches, strategic partnerships are some trends witnessed in the taxifolin market.

• Linjiang Jianwei Biotech Co., Ltd.
• KINGHERBS Limited
• JW Health Products Inc.
• KALENIKA Group
• Cayman Chemical Company, Inc.
• LKT Labs, Inc.
• Merck KGaA
• Abcam plc
• Adooq Bioscience LLC
• Hangzhou J&H Chemical Co., Ltd